Business Daily from THE HINDU group of publications
Friday, Apr 17, 2009
ePaper | Mobile/PDA Version | Audio | Blogs
Business Daily from THE HINDU group of publications Friday, Apr 17, 2009 ePaper | Mobile/PDA Version | Audio | Blogs |
|
|
|
|
|
Corporate
-
Alliances & Joint Ventures
Our Bureau Hyderabad, April 16 Natco Pharma Ltd has entered into an agreement with Dr Reddy’s Laboratories Ltd for development, manufacture and supply of value-added generic oncology drugs for global markets. A basket of currently selling oral and injectable innovator products, which have multi-million dollar sales across the world including Pacitaxel, a generic version of Abraxane, would be selected for generic development. Dr Reddy’s and Natco would develop these products jointly for registration and global commercialisation including the regulated markets of the US and EU. Natco would exclusively manufacture these products to be supplied to Dr Reddy’s for commercialisation. Dr Reddy’s would pay an undisclosed amount as upfront payment for Natco for securing rights to the product portfolio and capacity required to manufacture these products. In return, it would get exclusive territory specific and global commercialisation rights depending on the nature of the product. The profit would be shared by the two companies. For Natco, which already has over 12 oncology products in the market, the agreement would help recover the development costs and manufacturing expenses besides a share in the profit. For the long termThe long-term agreement (for over a period of 10 years) can be supplemented with future products to expand the strategic collaboration, Natco said in a release. Commenting on the deal, Mr Rajeev Nannapaneni, Chief Operating Officer, Natco Pharma, said: “We are impressed with Dr Reddy’s commercial infrastructure and commitment to oncology and are happy to come together to deliver value in the oncology space.” Oncology biz drives Natco’s net up 33% Dr Reddy's launches oncology drug Natco, Lupin tie-up for generic drug to treat kidney failure Mylan, Natco tie up to market drug More Stories on : Alliances & Joint Ventures | Pharmaceuticals | Dr. Reddy's Laboratories Ltd
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2009, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|
